Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled Trial
Clinical trial NCT02190357 · UNKNOWN
Trial details
- NCT number
- NCT02190357
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2018-08-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.